Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net income	$ 34,364,346	$ 9,755,160
Adjustments to reconcile net income to net cash used in operating activities:
Amortization (accretion) of investments	138,587	210,665
Other-than-temporary impairments	5,000,000	393,455
Realized investment gains, net	(14,168,911)	(6,021,653)
Change in fair value of equity securities	(33,690,712)	(14,121,883)
Unrealized trading (gains) losses included in income	1,086	(2,059)
Realized trading (gains) losses included in income	12,197	(20,509)
Amortization of cost of insurance acquired	688,348	714,970
Depreciation and depletion	2,032,627	2,757,522
Stock-based compensation	599,192	287,934
Charges for mortality and administration of universal life and annuity products	(5,943,417)	(6,325,818)
Interest credited to account balances	3,767,177	3,896,162
Change in accrued investment income	(107,518)	77,484
Change in reinsurance receivables	210,672	88,449
Change in policy liabilities and accruals	(2,836,498)	(5,470,342)
Change in income taxes receivable (payable)	5,164,454	(1,243,870)
Change in other assets and liabilities, net	(565,949)	2,570,898
Net cash used in operating activities	(5,334,319)	(12,453,435)
Proceeds from investments sold and matured:
Fixed maturities available for sale	13,128,136	21,581,106
Equity securities	36,126,454	5,892,777
Trading securities	17,983	41,708
Mortgage loans	3,655,779	12,270,055
Real estate	12,659,854	8,370,848
Notes receivable	12,329,505	8,639,320
Policy loans	1,752,613	2,503,273
Total proceeds from investments sold and matured	79,670,324	59,299,087
Cost of investments acquired:
Fixed maturities available for sale	(2,614,165)	(4,078,459)
Equity securities	(27,523,161)	(32,991,005)
Trading securities	(32,382)	(30,243)
Mortgage loans	(5,158,911)	(20,634,252)
Real estate	(4,586,280)	(10,960,910)
Notes receivable	(9,030,657)	(8,680,000)
Policy loans	(929,549)	(1,303,246)
Short-term investments	(3,591,885)	0
Total cost of investments acquired	(53,466,990)	(78,678,115)
Sale of property and equipment	0	1,324,647
Net cash provided by (used in) investing activities	26,203,334	(18,054,381)
Cash flows from financing activities:
Policyholder contract deposits	4,555,115	4,466,422
Policyholder contract withdrawals	(5,106,391)	(5,588,394)
Proceeds from notes payable/line of credit	58,500,000	24,000,000
Payments of principal on notes payable/line of credit	(63,500,000)	0
Purchase of treasury stock	(685,808)	(537,379)
Issuance of stock	0	5,005
Non controlling contributions/(distributions) of consolidated subsidiary	(128,824)	(76,314)
Net cash provided by (used in) financing activities	(6,365,908)	22,269,340
Net increase (decrease) in cash and cash equivalents	14,503,107	(8,238,476)
Cash and cash equivalents at beginning of period	30,787,278	39,025,754
Cash and cash equivalents at end of period	$ 45,290,385	$ 30,787,278